These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35297979)

  • 41. Driving errors in Parkinson's disease: moving closer to predicting on-road outcomes.
    Classen S; Brumback B; Monahan M; Malaty II; Rodriguez RL; Okun MS; McFarland NR
    Am J Occup Ther; 2014; 68(1):77-85. PubMed ID: 24367958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Automobile driving performance of brain-injured patients with visual field defects.
    Schulte T; Strasburger H; Müller-Oehring EM; Kasten E; Sabel BA
    Am J Phys Med Rehabil; 1999; 78(2):136-42. PubMed ID: 10088588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eye Movements of Drivers with Glaucoma on a Visual Recognition Slide Test.
    Lee SS; Black AA; Wood JM
    Optom Vis Sci; 2019 Jul; 96(7):484-491. PubMed ID: 31274736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the Predictive Ability of the Motor-Free Visual Perception Test (MVPT) and Trail Making Test (TMT) for On-Road Driving Performance.
    Holowaychuk A; Parrott Y; Leung AWS
    Am J Occup Ther; 2020; 74(5):7405205070p1-7405205070p8. PubMed ID: 32804625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simulator Pre-Screening of Underprepared Drivers Prior to Licensing On-Road Examination: Clustering of Virtual Driving Test Time Series Data.
    Grethlein D; Winston FK; Walshe E; Tanner S; Kandadai V; Ontañón S
    J Med Internet Res; 2020 Jun; 22(6):e13995. PubMed ID: 32554384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glaucoma and Driving License: How to Identify Patients at Risk of Revocation.
    Landini L; Donati S; Digiuni M; Feltre S; Corsini G; Premi E; Radice P; Azzolini C
    J Curr Glaucoma Pract; 2022; 16(2):117-123. PubMed ID: 36128076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing visual fields for driving in patients with paracentral scotomata.
    Chisholm CM; Rauscher FG; Crabb DC; Davies LN; Dunne MC; Edgar DF; Harlow JA; James-Galton M; Petzold A; Plant GT; Viswanathan AC; Underwood GJ; Barbur JL
    Br J Ophthalmol; 2008 Feb; 92(2):225-30. PubMed ID: 17962396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low vision rehabilitation: vision requirements for driving.
    Colenbrander A; Fletcher DC
    J Ophthalmic Nurs Technol; 1992; 11(3):111-5. PubMed ID: 1597866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of visual impairment on driving.
    Wood JM; Troutbeck R
    Hum Factors; 1994 Sep; 36(3):476-87. PubMed ID: 7989052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On-road Driving Performance of Patients With Bilateral Moderate and Advanced Glaucoma.
    Bhorade AM; Yom VH; Barco P; Wilson B; Gordon M; Carr D
    Am J Ophthalmol; 2016 Jun; 166():43-51. PubMed ID: 26949136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survey of older drivers' experiences with Florida's mandatory vision re-screening law for licensure.
    McGwin G; McCartt AT; Braitman KA; Owsley C
    Ophthalmic Epidemiol; 2008; 15(2):121-7. PubMed ID: 18432496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Visual field defects after epilepsy surgery: implications for driving license tenure].
    Beisse F; Lagrèze WA; Schmitz J; Schulze-Bonhage A
    Ophthalmologe; 2014 Oct; 111(10):942-7. PubMed ID: 24577848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
    Akinwuntan AE; Devos H; Stepleman L; Casillas R; Rahn R; Smith S; Williams MJ
    Mult Scler; 2013 Mar; 19(3):344-50. PubMed ID: 22760100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantifying visual road environment to establish a speeding prediction model: An examination using naturalistic driving data.
    Yu B; Chen Y; Bao S
    Accid Anal Prev; 2019 Aug; 129():289-298. PubMed ID: 31177040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Driving Characteristics of Older Drivers and Their Relationship to the Useful Field of View Test.
    Dukic Willstrand T; Broberg T; Selander H
    Gerontology; 2017; 63(2):180-188. PubMed ID: 27764828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visual field assessment and the Austroads driving standard.
    McLean IM; Mueller E; Buttery RG; Mackey DA
    Clin Exp Ophthalmol; 2002 Feb; 30(1):3-7. PubMed ID: 11885792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vision and drivers--a South Wales survey.
    Anuradha S; Potter C; Fernquest G
    J Public Health (Oxf); 2007 Sep; 29(3):230-5. PubMed ID: 17567678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vision and driving: Canada.
    Yazdan-Ashoori P; Ten Hove M
    J Neuroophthalmol; 2010 Jun; 30(2):177-85. PubMed ID: 20523185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glaucomatous visual fields and neurocognitive function are independently associated with poor lane maintenance during driving simulation.
    Anderson DE; Bader JP; Boes EA; Gagrani M; Smith LM; Ndulue JK; Kedar S; Gulati V; Ghate DA; Rizzo M
    BMC Ophthalmol; 2020 Oct; 20(1):419. PubMed ID: 33081721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 'I didn't see that coming': simulated visual fields and driving hazard perception test performance.
    Glen FC; Smith ND; Jones L; Crabb DP
    Clin Exp Optom; 2016 Sep; 99(5):469-75. PubMed ID: 27489171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.